HilleVax (NASDAQ:HLVX) Releases Earnings Results, Misses Expectations By $0.02 EPS

HilleVax (NASDAQ:HLVX) posted its quarterly earnings data on Friday. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.33) by ($0.02), Zacks reports.

HilleVax Price Performance

NASDAQ:HLVX traded down $0.02 during trading hours on Friday, reaching $1.59. 97,820 shares of the stock were exchanged, compared to its average volume of 430,237. HilleVax has a twelve month low of $1.55 and a twelve month high of $16.66. The stock has a market cap of $79.19 million, a PE ratio of -0.51 and a beta of 0.76. The firm has a 50 day moving average of $1.82 and a 200 day moving average of $1.86.

About HilleVax

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.